相似文献
1
Clinical practice guidelines in cancer: the European perspective.
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):6-7. doi: 10.1054/bjoc.2000.1773.
2
SOR Project: the French context.
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):4-5. doi: 10.1054/bjoc.2000.1756.
3
'Background to clinical guidelines in cancer': SOR, a programmatic approach to guideline development and aftercare.
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):1-3. doi: 10.1054/bjoc.2000.1755.
4
NICE guidance, but who does the work?
Clin Oncol (R Coll Radiol). 2011 Feb;23(1):1-3. doi: 10.1016/j.clon.2010.09.008. Epub 2010 Oct 14.
5
SOR: project methodology.
Br J Cancer. 2001 May;84 Suppl 2(Suppl 2):8-16. doi: 10.1054/bjoc.2000.1757.
6
New standards and implications for improving the quality of supportive oncology practice.
J Clin Oncol. 2008 Aug 10;26(23):3824-31. doi: 10.1200/JCO.2007.15.7552.
7
Identification, validation, and clinical implementation of tumor-associated biomarkers to improve therapy concepts, survival, and quality of life of cancer patients: tasks of the Receptor and Biomarker Group of the European Organization for Research and Treatment of Cancer.
Int J Oncol. 2004 Nov;25(5):1397-406.
8
Possibilities for transborder cooperation in breast cancer care in Europe: a comparative analysis regarding the content, quality and evidence use of breast cancer guidelines.
Breast. 2008 Oct;17(5):464-71. doi: 10.1016/j.breast.2008.01.008. Epub 2008 May 1.
9
Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries.
Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):509-15. doi: 10.1097/HJR.0b013e328302f44d.
10
[International comparison of 19 clinical guideline programs--a survey of the AGREE Collaboration].
Z Arztl Fortbild Qualitatssich. 2003 Feb;97(1):81-8.
本文引用的文献
1
Biomedical ethics. Penn report, agency heads home in on clinical research.
Science. 2000 Jun 2;288(5471):1558-9. doi: 10.1126/science.288.5471.1558.
2
New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.
J Natl Cancer Inst. 2000 Feb 2;92(3):205-16. doi: 10.1093/jnci/92.3.205.
3
Outcomes research in oncology: history, conceptual framework, and trends in the literature.
J Natl Cancer Inst. 2000 Feb 2;92(3):195-204. doi: 10.1093/jnci/92.3.195.
4
Survival of cancer patients in Finland 1955-1994.
Acta Oncol. 1999;38 Suppl 12:1-103. doi: 10.1080/028418699432996.
5
Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group.
Eur J Cancer. 1998 Dec;34(14 Spec No):2204-11. doi: 10.1016/s0959-8049(98)00323-2.
6
The promise and problems of meta-analysis.
N Engl J Med. 1997 Aug 21;337(8):559-61. doi: 10.1056/NEJM199708213370810.
7
Discrepancies between meta-analyses and subsequent large randomized, controlled trials.
N Engl J Med. 1997 Aug 21;337(8):536-42. doi: 10.1056/NEJM199708213370806.
Zotero 插件